Developing a Pseudomonas aeruginosa keratitis model in Swiss albino mice for clinical assessment

Lalan Kumar Arya1, Anita Kumari1, Rakhi Kusumesh1

  • 1Regional Institute of Ophthalmology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.

Insights

A new, simplified mouse model using Swiss albino mice effectively replicates Pseudomonas aeruginosa bacterial keratitis. This cost-effective model aids research into disease mechanisms and treatments for this severe eye infection.

Area of Science:

  • Ophthalmology
  • Microbiology
  • Infectious Diseases

Background:

  • Pseudomonas aeruginosa is a primary cause of bacterial keratitis, leading to rapid, severe corneal damage and treatment resistance.
  • Current animal models for studying P. aeruginosa keratitis are often complex and require specialized conditions.
  • There is a need for a simplified, reproducible, and cost-effective model for translational research.

Purpose of the Study:

  • To develop and validate a simplified, cost-effective, and reproducible murine model of P. aeruginosa keratitis.
  • To utilize Swiss albino mice for studying bacterial keratitis relevant to human disease.
  • To facilitate translational research applications in ophthalmic infections.

Main Methods:

  • Swiss albino mice underwent corneal abrasion followed by topical inoculation with P. aeruginosa.
  • Clinical signs of keratitis were assessed using a standardized scoring scale over three days.
  • Infection confirmation involved bacterial culture, biochemical tests, and PCR for the exotoxin A gene.

Main Results:

  • All infected mouse eyes developed progressive keratitis, including lid swelling, corneal haze, and stromal involvement.
  • Control eyes remained healthy, demonstrating the model's specificity.
  • Clinical scores significantly increased over time (P<0.05), and infection was confirmed by culture and molecular methods.

Conclusions:

  • This simplified Swiss albino mouse model accurately mimics human P. aeruginosa keratitis.
  • The model provides a cost-effective platform for investigating bacterial keratitis pathogenesis.
  • It enables efficient therapeutic testing and supports standardized ophthalmic infection research.

Related Concept Videos